About Artificial cell technologies

About company

Artificial Cell Technologies (ACT) is redefining the manufacturing of globally available vaccines. This New Haven based firm is actively developing the first patented technology for rapid, synthetic vaccine production. Their unique approach allows ACT to produce multi-valent vaccines exponentially faster, and capable of personalization. This also allows the vaccines to be produced on-demand.